Latest News

Key Insights Using the 2 Stage Free Cash Flow to Equity, Wasion Holdings fair value estimate is HK$40.31 Wasion...

PPK Group Limited ( ASX:PPK ) shares have had a really impressive month, gaining 25% after a shaky period beforehand...

When close to half the companies in India have price-to-earnings ratios (or "P/E's") below 24x, you may consider BSE...

For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...

If you're looking for a multi-bagger, there's a few things to keep an eye out for. Amongst other things, we'll want to...

Melbourne Enterprises Limited ( HKG:158 ) is reducing its dividend from last year's comparable payment to HK$1.60 on...

What trends should we look for it we want to identify stocks that can multiply in value over the long term? Ideally, a...

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...

Maanshan Iron & Steel Company Limited's ( HKG:323 ) price-to-sales (or "P/S") ratio of 0.2x might make it look like a...

Key Insights The considerable ownership by public companies in ABB India indicates that they collectively have a...

Key Insights Significantly high institutional ownership implies Fisher & Paykel Healthcare's stock price is sensitive...

Hengxin Technology Ltd. ( HKG:1085 ) shareholders would be excited to see that the share price has had a great month...

Hang Lung Properties Limited's ( HKG:101 ) price-to-earnings (or "P/E") ratio of 23.8x might make it look like a strong...

When you buy shares in a company, it's worth keeping in mind the possibility that it could fail, and you could lose...

Pentanet Limited ( ASX:5GG ) shareholders would be excited to see that the share price has had a great month, posting a...

To find a multi-bagger stock, what are the underlying trends we should look for in a business? One common approach is...

Key Insights Significant control over Tokyo Kiraboshi Financial Group by individual investors implies that the general...

Key Insights Iljin ElectricLtd's significant public companies ownership suggests that the key decisions are influenced...

Did you know there are some financial metrics that can provide clues of a potential multi-bagger? Typically, we'll want...

Sila Realty Trust, Inc. recently completed the US$43.1 million acquisition of a fully leased inpatient rehabilitation facility in Oklahoma City, Oklahoma, which has been expanded to 58 beds and is operated under a long-term absolute-net lease with a corporate guaranty. This transaction reinforces Sila Realty Trust’s focus on healthcare real estate anchored by long-duration, necessity-based assets with strong occupancy and limited local competition, aiming to support consistent cash...

Voltalia (ENXTPA:VLTSA) has drawn fresh attention after guiding that its net loss attributable to the Group in the second half of 2025 will be higher than in the first half, sharpening investor focus on profitability. See our latest analysis for Voltalia. At a share price of €7.32, Voltalia has seen a 4.2% 1 month share price return, while the 1 year total shareholder return of 8.9% contrasts with a much weaker 3 and 5 year total shareholder return, suggesting recent momentum is tentative...

Why Nobia’s rights issue and UK exit matter for shareholders Nobia (OM:NOBI) is overhauling its business by selling its UK operations, refocusing on Nordic markets, and raising approximately SEK 1.5b through a rights issue, together with new loan agreements and planned capital structure changes. See our latest analysis for Nobia. The rights issue, UK exit and refinancing have come against a weak share price backdrop, with a 7 day share price return of 27.12% decline and a 5 year total...

Erasca recently reported encouraging early Phase 1 AURORAS-1 data for its pan-RAS molecular glue degrader ERAS-0015, showing multiple partial responses across RAS-mutated tumor types with a clean safety profile and linear pharmacokinetics, while ERAS-4001 continued dose escalation in the BOREALIS-1 trial. What makes this update particularly interesting is that meaningful anti-tumor activity emerged at a relatively low 8 mg once-daily dose, potentially widening the drug’s future dosing window...

Why Vertiv Holdings Co (VRT) Is On Investors’ Radar Vertiv Holdings Co (VRT) has drawn attention after a recent move in its share price, with the stock last closing at $176.93, putting recent returns and fundamentals in focus for investors. See our latest analysis for Vertiv Holdings Co. Recent moves fit into a mixed picture, with a 1-day share price return of 2.54% and 7-day gain of 8.16%, alongside a modest 90-day share price return of 0.68%. At the same time, the 1-year total shareholder...